MusclePharm Corp Contracts & Agreements
153 Contracts & Agreements
- Business Finance (80 contracts)
- Business Operations (10)
- Human Resources (29)
- Real Estate (1)
- Uncategorized (33)
- Separation and Release Agreement between the Company and Sabina Rizvi dated July 22, 2022 (Filed With SEC on July 28, 2022)
- Drexler November Note, as amended (Filed With SEC on June 14, 2022)
- Drexler August Note, as amended (Filed With SEC on June 14, 2022)
- Amendment to Ryan Drexlers Amended and Restated Employment Agreement dated June 10, 2022 (Filed With SEC on June 14, 2022)
- Small Business Administration Loan Agreement between MusclePharm Corporation and Harvest Small Business Finance, LLC (Filed With SEC on April 15, 2022)
- Unsecured Revolving Promissory Note, dated March 8, 2022, between MusclePharm Corporation and Ryan Drexler (Filed With SEC on March 11, 2022)
- First Amendment to Intercreditor and Subordination Agreement, dated March 8, 2022, between MusclePharm Corporation, Ryan Drexler and Empery Tax Efficient, LP (Filed With SEC on March 11, 2022)
- Intercreditor and Subordination Agreement, dated October 13, 2021, between MusclePharm Corporation, Ryan Drexler and Empery Tax Efficient, LP (Filed With SEC on March 11, 2022)
- Amendment to Settlement Agreement, Dated September 23, 2021 between the Company and NBF Holdings Canada Inc (Filed With SEC on November 17, 2021)
- Form of Warrant (Filed With SEC on October 19, 2021)
- Form of Senior Note (Filed With SEC on October 19, 2021)
- Securities Purchase Agreement, dated October 13, 2021, by and between MusclePharm Corp. and the parties thereto (Filed With SEC on October 19, 2021)
- Pledge and Security Agreement, dated October 13, 2021, by and between MusclePharm Corp. and the parties thereto (Filed With SEC on October 19, 2021)
- Letter agreement, dated May 12, 2021 between the Company and Joseph Cannata (Filed With SEC on August 16, 2021)
- Letter agreement, dated April 1, 2021 between the Company and Sabina Rizvi (Filed With SEC on May 24, 2021)
- Small Business Administration Loan Agreement between MusclePharm Corporation and Harvest Small Business Finance, LLC (Filed With SEC on March 29, 2021)
- Settlement Agreement, dated November 7, 2020 by and between MusclePharm Corporation and Excelsior Nutrition, Inc. (4Excelsior) (Filed With SEC on March 29, 2021)
- Convertible Secured Promissory Note, dated November 29, 2020, between MusclePharm Corporation and Ryan Drexler (Filed With SEC on December 3, 2020)
- Sixth Amended and Restated Security Agreement, dated November 29, 2020, between MusclePharm Corporation and Ryan Drexler (Filed With SEC on December 3, 2020)
- Settlement Agreement between MusclePharm Corporation and NBF Holdings Canada Inc., dated September 25, 2020 (Filed With SEC on November 24, 2020)
- SecuredRevolvingPromissoryNote, dated October 15, 2020, between MusclePharm Corporation and Ryan Drexler (Filed With SEC on October 21, 2020)
- Fifth Amended and Restated Security Agreement, dated October 15, 2020, between MusclePharm Corporation and Ryan Drexler (Filed With SEC on October 21, 2020)
- Amended and Restated Convertible Secured Promissory Note, dated August 21, 2020, between MusclePharm Corporation and Ryan Drexler (Filed With SEC on August 27, 2020)
- Fourth Amended and Restated Security Agreement, datedAugust 21, 2020, between MusclePharm Corporation and Ryan Drexler (Filed With SEC on August 27, 2020)
- Separation and Release Agreement, dated May 1, 2020 between the Company and Brian Casutto (Filed With SEC on May 7, 2020)
- Offer Letter, dated as of December 13, 2019 entered into between the Company and Troy Bolotnick (Filed With SEC on December 19, 2019)
- Secured Revolving Promissory Note, dated October 4, 2019, between MusclePharm Corporation and Ryan Drexler (Filed With SEC on October 10, 2019)
- Security Agreement, dated October 4, 2019, between MusclePharm Corporation and Ryan Drexler (Filed With SEC on October 10, 2019)
- Lease Agreement for the Corporate Headquarters located in Burbank, CA effective October 1, 2017 (Filed With SEC on April 2, 2018)
- Executive Employment Agreement, between MusclePharm Corporation and Brian Casutto (Filed With SEC on April 2, 2018)
- Amended and Restated Executive Employment Agreement, dated as of February 26, 2018, effective as of February 1, 2018, entered into between the Company and Ryan Drexler (Filed With SEC on March 1, 2018)
- Transaction Bonus Agreement, dated as of February 26, 2018, entered into between the Company and Ryan Drexler (Filed With SEC on March 1, 2018)
- Amended and Restated Convertible Secured Promissory Note, dated November 3, 2017, between MusclePharm Corporation and Ryan Drexler (Filed With SEC on November 8, 2017)
- Third Amended and Restated Security Agreement, dated November 3, 2017, between MusclePharm Corporation and Ryan Drexler (Filed With SEC on November 8, 2017)
- Restructuring Agreement, dated November 3, 2017, between MusclePharm Corporation and Ryan Drexler (Filed With SEC on November 8, 2017)
- Loan and Security Agreement (Filed With SEC on October 10, 2017)
- Form of Indemnification Agreement (Filed With SEC on September 8, 2017)
- Amended and Restated Executive Employment Agreement, dated as of January 14, 2017, between the Company and Ryan Drexler (Filed With SEC on August 14, 2017)
- Secured Demand Promissory Note, dated July 27, 2017, between MusclePharm Corporation and Ryan Drexler (Filed With SEC on July 31, 2017)
- Second Amended and Restated Security Agreement, dated July 27, 2017, between MusclePharm Corporation and Ryan Drexler (Filed With SEC on July 31, 2017)
- CONVERTIBLE SECURED PROMISSORY NOTE (Filed With SEC on March 15, 2017)
- FIRST AMENDMENT TO CONVERTIBLE SECURED PROMISSORYNOTE (Filed With SEC on March 15, 2017)
- W I T N E S S E T H: (Filed With SEC on November 25, 2016)
- WARRANT (Filed With SEC on November 9, 2016)
- Convertible Secured PromissoryNote (Filed With SEC on November 9, 2016)
- Amended and RestatedSecurity Agreement (Filed With SEC on November 9, 2016)
- SETTLEMENT AGREEMENT (Filed With SEC on November 9, 2016)
- between MusclePharmCorporation and BioZoneHoldings, Inc. and biozonelaboratories, inc. datedas of April21, 2016 (Filed With SEC on April 27, 2016)
- DEBT MODIFICATION AGREEMENT TERM LOAN (Filed With SEC on March 17, 2016)
- DEBT MODIFICATION AGREEMENT REVOLVING LINE OF CREDIT (Filed With SEC on March 17, 2016)
- INDIVIDUAL GUARANTY October 9, 2015 (Filed With SEC on March 17, 2016)
- INDIVIDUAL GUARANTY October 9, 2015 (Filed With SEC on March 17, 2016)
- EXECUTIVE EMPLOYMENTAGREEMENT (Filed With SEC on February 16, 2016)
- SEPARATION AGREEMENT (Filed With SEC on August 10, 2015)
- SEPARATION AGREEMENT (Filed With SEC on August 10, 2015)
- SEPARATION AGREEMENT (Filed With SEC on August 10, 2015)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 10, 2015)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 10, 2015)
- CONFIDENTIALITY AND NON-DISCLOSURE AGREEMENT (Filed With SEC on August 10, 2015)
- FIRST AMENDMENT TO MANUFACTURING AGREEMENT (Filed With SEC on May 11, 2015)
- REFERRAL AGREEMENT (Filed With SEC on May 11, 2015)
- INI PARENT, INC. CLASS B COMMON STOCK PURCHASE WARRANT AGREEMENT (Filed With SEC on May 11, 2015)
- OPTION AGREEMENT (Filed With SEC on May 11, 2015)
- EXECUTIVEEMPLOYMENT AGREEMENT (Filed With SEC on May 1, 2015)
- LOAN NUMBER ###-###-#### NOTE AMOUNT $4,000,000.00 (Filed With SEC on February 26, 2015)
- LOAN NUMBER ###-###-#### NOTE AMOUNT $4,000,000.00 (Filed With SEC on February 26, 2015)
- SECURITY AGREEMENT (Filed With SEC on February 26, 2015)
- Separation and Release of Claims Agreement (Filed With SEC on October 21, 2014)
- LOAN NUMBER ###-###-#### NOTE AMOUNT $8,000,000.00 (Filed With SEC on September 17, 2014)
- LOAN NUMBER 0135 16420 1 NOTE AMOUNT $8,000,000.00 (Filed With SEC on September 17, 2014)
- SECURITY AGREEMENT (Filed With SEC on September 17, 2014)
- EXECUTIVEEMPLOYMENT AGREEMENT (Filed With SEC on August 1, 2014)
- EXECUTIVEEMPLOYMENT AGREEMENT (Filed With SEC on August 1, 2014)
- SECOND AMENDMENT TO THE AMENDED AND RESTATEEXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 1, 2014)
- SECOND AMENDMENT TO THE AMENDED AND RESTATEDEXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 1, 2014)
- Separation and Release of Claims Agreement (Filed With SEC on April 14, 2014)
- VENDOR AGREEMENT (Filed With SEC on March 31, 2014)
- ENDORSEMENT LICENSING AND CO-BRANDINGAGREEMENT (Filed With SEC on March 31, 2014)
- EXECUTIVEEMPLOYMENT AGREEMENT (Filed With SEC on December 31, 2013)
- ASSET PURCHASE AGREEMENT by and among MUSCLEPHARM CORPORATION, BIOZONE LABORATORIES INC., and BIOZONE PHARMACEUTICALS, INC., BIOZONE LABORATORIES, INC., BAKER CUMMINS CORP. and... (Filed With SEC on November 13, 2013)
- EXECUTIVEEMPLOYMENT AGREEMENT (Filed With SEC on October 3, 2013)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 30, 2013)
- BIOZONE PHARMACEUTICALS, INC. SECURED CONVERTIBLE PROMISSORY NOTE (Filed With SEC on August 30, 2013)
- BIOZONE PHARMACEUTICALS, INC. Warrant (Filed With SEC on August 30, 2013)
- FORM OF ENDORSEMENT LICENSING AND CO-BRANDINGAGREEMENT (Filed With SEC on August 1, 2013)
- MusclePharm Corporation RESTRICTED STOCK AGREEMENT (Non-Assignable) (Filed With SEC on July 5, 2013)
- MusclePharm Corporation RESTRICTED STOCK AGREEMENT (Non-Assignable) (Filed With SEC on July 5, 2013)
- MusclePharm Corporation RESTRICTED STOCK AGREEMENT (Non-Assignable) (Filed With SEC on July 5, 2013)
- MusclePharm Corporation RESTRICTED STOCK AGREEMENT (Non-Assignable) (Filed With SEC on July 5, 2013)
- FIRST AMENDMENT TO THE CONSULTING AGREEMENT (Filed With SEC on April 5, 2013)
- FIRST AMENDMENT TO THE CONSULTING AGREEMENT (Filed With SEC on April 5, 2013)
- SUBSCRIPTIONAGREEMENT (Filed With SEC on March 28, 2013)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 28, 2013)
- MusclePharm Corporation Corporate stock transfer,inc. Transfer fee: As required (Filed With SEC on January 28, 2013)
- SUBSCRIPTION AGREEMENT (Filed With SEC on January 28, 2013)
- PLACEMENT AGENCY AGREEMENT January 16, 2013 (Filed With SEC on January 23, 2013)
- FORM OF PLACEMENT AGENCY AGREEMENT _____________, 201_ (Filed With SEC on December 31, 2012)
- MusclePharm Corporation CORPORATE STOCK TRANSFER, INC. TRANSFER FEE: AS REQUIRED (Filed With SEC on December 31, 2012)
- ESCROW DEPOSIT AGREEMENT (Filed With SEC on December 31, 2012)
- Form of Subscription Agreement (Filed With SEC on December 31, 2012)
- FORM OF PLACEMENT AGENCY AGREEMENT _____________, 201_ (Filed With SEC on December 26, 2012)
- FORM OF ESCROW AGREEMENT (Filed With SEC on December 26, 2012)
- Form of Subscription Agreement (Filed With SEC on December 26, 2012)
- PROMISSORY NOTE (Filed With SEC on December 10, 2012)
- SUBSCRIPTION AGREEMENT (Filed With SEC on December 10, 2012)
- NOTICE OF RESTRICTED STOCK UNIT AWARD (Filed With SEC on November 21, 2012)
- AMENDED AND RESTATED EXECUTIVE EMPLOYMENTAGREEMENT (Filed With SEC on October 24, 2012)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on October 24, 2012)
- AMENDED AND RESTATED EXECUTIVE EMPLOYMENTAGREEMENT (Filed With SEC on October 24, 2012)
- AMENDED AND RESTATED EXECUTIVE EMPLOYMENTAGREEMENT (Filed With SEC on October 24, 2012)
- AMENDED AND RESTATED EXECUTIVE EMPLOYMENTAGREEMENT (Filed With SEC on October 24, 2012)
- INDEMNIFICATION AGREEMENT (Filed With SEC on August 27, 2012)
- COMMITTED EQUITY FACILITY AGREEMENT (Filed With SEC on July 20, 2012)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on July 20, 2012)
- PROMISSORY NOTE (Filed With SEC on July 20, 2012)
- SECURITY AGREEMENT (Filed With SEC on July 20, 2012)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on July 19, 2012)
- CONSULTING AGREEMENT (Filed With SEC on July 19, 2012)
- CONSULTING AGREEMENT (Filed With SEC on July 19, 2012)
- AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on April 16, 2012)
- AMENDED AND RESTATEDEMPLOYMENT AGREEMENT (Filed With SEC on April 16, 2012)
- FORM OF PROMISSORY NOTE (Filed With SEC on March 8, 2012)
- FORM OF COMMON STOCK PURCHASE WARRANT (Filed With SEC on March 8, 2012)
- MUSCLEPHARM CORPORATION (The "Company") SUBSCRIPTION AGREEMENT To be fully completed by Subscriber (Filed With SEC on March 8, 2012)
- PROMISSORY NOTE (Filed With SEC on December 29, 2011)
- PROMISSORY NOTE (Filed With SEC on December 29, 2011)
- EQUITY PURCHASE AGREEMENT BY AND BETWEEN MUSCLEPHARM CORPORATION AND SOUTHRIDGE PARTNERS II, LP Dated November 4, 2011 (Filed With SEC on December 29, 2011)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 29, 2011)
- FORM OF PROMISSORY NOTE (Filed With SEC on December 13, 2011)
- FORM OF COMMON STOCK PURCHASE WARRANT (Filed With SEC on December 13, 2011)
- MUSCLEPHARM CORPORATION (The "Company") SUBSCRIPTION AGREEMENT To be fully completed by Subscriber (Filed With SEC on December 13, 2011)
- AMENDMENT NO. 1 Dated as of December 8, 2011 to STOCK PURCHASE AGREEMENT dated July 7, 2011 by and between CARRIAGE GROUP, LLC, and MUSCLEPHARM CORPORATION AMENDMENT TO STOCK... (Filed With SEC on December 9, 2011)
- STOCK PURCHASE AGREEMENT (Filed With SEC on December 8, 2011)
- COMPANY NOTE (Filed With SEC on November 14, 2011)
- MUSCLEPHARM CORPORATION WARRANT TO PURCHASE SHARES OF COMMON STOCK (Filed With SEC on November 14, 2011)
- NOTE AND WARRANT PURCHASE AGREEMENT (Filed With SEC on November 14, 2011)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on November 14, 2011)
- EMPLOYMENT AGREEMENT (Filed With SEC on November 14, 2011)
- AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on November 14, 2011)
- EMPLOYMENT AGREEMENT (Filed With SEC on November 14, 2011)
- PROMISSORY NOTE (Filed With SEC on September 27, 2011)
- PROMISSORY NOTE (Filed With SEC on September 27, 2011)
- EMPLOYMENT AGREEMENT (Filed With SEC on August 16, 2011)
- EMPLOYMENT AGREEMENT (Filed With SEC on August 16, 2011)
- ENDORSEMENT AGREEMENT (Filed With SEC on July 22, 2011)
- STOCK PURCHASE AGREEMENT (Filed With SEC on July 19, 2011)
- CONVERTIBLE PROMISSORY NOTE $900,000 PLUS INTEREST DUE & PAYABLE DOCUMENT A-06072011 (Filed With SEC on July 8, 2011)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on July 8, 2011)
- SPONSORSHIP AGREEMENT (Filed With SEC on January 24, 2011)
- CONVERTIBLEPROMISSORY NOTE $1,650,000PLUS INTEREST DUE & PAYABLE DOCUMENTA-12012010 (Filed With SEC on December 10, 2010)
- REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on December 10, 2010)
- PURCHASINGAGREEMENT (Filed With SEC on February 24, 2010)
- ALIVE MEDIA GROUP Television | Media | Marketing Production and Advertising Agreement Alive & WellTV/ Vitamin Shoppe TV (Filed With SEC on February 24, 2010)